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Genetic induction of hypoxia signaling by deletion of the
von Hippel-Lindau (Vhl) protein in mesenchymal PDGFR-
bD cells leads to abundant HIF-2 dependent erythropoietin
(EPO) expression in the cortex and outer medulla of the
kidney. This rather unique feature of kidney PDGFR-bD
cells promote questions about their special characteristics
and general functional response to hypoxia. To address
these issues, we characterized kidney PDGFR-bD EPO
expressing cells based on additional cell markers and their
gene expression profile in response to hypoxia signaling
induced by targeted deletion of Vhl or exposure to low
oxygen and carbon monoxide respectively, and after
unilateral ureteral obstruction. CD73D, Gli1D, tenascin CD
and interstitial SMMHCD cells were identified as zonally
distributed subpopulations of PDGFR-bD cells. EPO
expression could be induced by Vhl deletion in all PDGFR-
bD subpopulations. Under hypoxemic conditions, recruited
EPOD cells were mostly part of the CD73D subpopulation.
Besides EPO production, expression of adrenomedullin and
regulator of G-protein signaling 4 was upregulated in
PDGFR-bD subpopulations in response to the different
hypoxic stimuli. Thus, different kidney interstitial PDGFR-
bD subpopulations exist, capable of producing EPO in
response to different stimuli. Activation of hypoxia
signaling in these cells also induces factors likely
contributing to improved kidney interstitial tissue
oxygenation.
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T
he kidneys are the main site of oxygen-regulated eryth-
ropoietin (EPO) production. Within the kidneys, tubu-
lointerstitial cells produce EPO1,2 triggered by hypoxia
inducible factor 2 (HIF-2).3 The regulation of renal EPO pro-
duction occurs mainly by recruitment of EPO-producing cells
that express EPO in an on/off fashion.4 In the normoxic kid-
ney, few EPO-expressing cells are found at the boundary be-
tween cortex and outer medulla (OM), whereas under severe
hypoxic stress, EPO-expressing cells are recruited in the whole
cortex and OM.5–7 The identity and functional characteristics
of those active and potentially EPO-producing cells are less
clear. Originally, EPO-producing cells had been identified as
interstitial fibroblast-like cells expressing CD73 (ecto-50-
nucleotidase).1 More recent studies have suggested that in
addition to CD73þ cells, also other cell types are able to ex-
press EPO.8 Such a heterogeneity of renal EPO-producing
cells has also been suggested by data from mice lacking HIF
prolyl-4-hydroxylases in renal stroma cell precursors9 and
has received support by the concept that EPO-producing cells
could be telocytes10 or pericytes.11 EPO-producing cells have
a stellate form with multiple extensions such as peri-
cytes,10,12,13 and they are located directly adjacent to capil-
laries.1,5,12 Moreover, pericytes are key players in renal
fibrosis.11 Potential EPO-producing cells are the precursors
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Translational Statement
Tissue oxygenation is dependent on proper erythropoi-
etin (EPO) production and local regulatory factors. We
investigated different subpopulations of possible EPO-
producing cells in the mouse kidney under hypoxemic
stimuli and experimental kidney fibrosis. These cells
comprise a heterogeneous group of interstitial cells,
which share the expression of PDGFR-b. Induction of
hypoxia signaling in these cells induces the expression of
factors supporting tissue oxygenation. These data could
provide a starting point for closer investigations of the
fine regulation of tissue oxygenation. In addition, the
here-defined subpopulations of PDGFR-bþ interstitial
cells could present new targets for a pharmacologic
approach to treat EPO deficiency.
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of myofibroblasts in the kidney14 and the ability of the kid-
neys to produce EPO ceases with interstitial myofibroblast
formation in states of kidney fibrosis.12,15–17 This concept of
EPO-producing cells being pericytes, however, is somewhat
contradicted by the fact that classical pericytes are located
mainly in the OM and to a lesser extent in the cortex.18
The pericyte concept is also questioned by the finding that
HIF stabilization in cells expressing the fibroblast cell marker
PDGFR-b19 strongly induces EPO expression in the intersti-
tium of the cortex and the OM,13 whereas HIF stabilization
in cells expressing the pericyte marker NG219 only negligibly
induces EPO expression in the kidney.20 All renal cells with
inducible EPO expression appear to express PDGFR-b, thus
defining PDGFR-b as an essential marker of renal EPO-
Figure 1 | Localization of PDGFR-bD cells and additional markers on mouse kidney sections in different kidney zones. Interstitial
PDGFR-bþ cells were distributed over all kidney zones (green in top and bottom row, red in middle rows), with the highest number in the
cortex. Intraglomerular mesangial cells were also positive for PDGFR-b. Bars ¼ 50 mm. Top row: a strong colocalization for CD73 (red) and
PDGFR-b (green) mRNA could be detected in interstitial cells of the cortex and the outer stripe of the outer medulla (osOM), but not in the
inner stripe of the outer medulla (isOM) or inner medulla (IM). CD73 expression was also found in mesangial cells and proximal tubular cells
(arrows). Second row: immunohistochemical staining for green fluorescent protein (GFP) (green) and PDGFR-b (red) on a Gli1CreERT2/þ mT/mG
kidney section. The Gli1-GFP signal was located in cortical and outer medullary interstitial cells and colocalized with PDGFR-b in yellow-
appearing cells. Gli1-GFP/PDGFR-b colocalization was almost undetectable in the IM. Third row: immunohistochemical staining for SMMHC-
driven GFP (green) on a kidney section of an SMMHCCreERT2/þ mT/mG mouse. Colocalization of SMMHC-GFP (green) and PDGFR-b (red) was
detectable in approximately 10% of all interstitial PDGFR-bþ cells in the OM, especially in the isOM. In the cortex and in the IM, colocalization
was very low. Bottom row: in situ hybridization for tenascin C (TNC; red) and PDGFR-b (green) mRNA. In the cortex, coexpression in interstitial
cells was very low (<5%), but TNC expression could be detected around glomeruli (arrows), presumably in the Bowman's capsules.
Colocalization in the osOM was also very low (<5%). In the isOM, colocalization increased to 65% and to 100% in the IM. To optimize viewing
of this image, please see the online version of this article at www.kidney-international.org/.
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producing cells.13 PDGFR-bþ cells exist in all organs but
physiologically regulated EPO production in these cells ap-
pears to be restricted to the kidneys and the brain.13,20 The
restriction of EPO expression to the kidneys is likely not
the result of organ-specific differences of oxygen sensing,
but is rather due to the selective ability of renal PDGFR-bþ
cells to express EPO. This assumption is supported by the
finding that cell-type–specific stabilization of HIF-proteins
in PDGFR-bþ cells by deletion of the ubiquitin ligase von
Hippel-Lindau induces EPO expression substantially only in
the kidneys (and to a low degree also in adrenal glands).13
This organ specificity of EPO expression raised the question
about other structural and functional characteristics of renal
EPO-producing PDGFR-bþ cells.
So far, different tubulointerstitial cell types have been
identified: cells specifically expressing CD73,1,2 the mesen-
chymal progenitor cell marker Gli1,21 the extracellular matrix
protein tenascin C (TNC),22 or markers for contractile peri-
cytes.19,23 We were interested to see which of these renal
interstitial cell (RIC) populations carry PDGFR-b and if they
are capable of producing EPO in response to HIF stabiliza-
tion. To address these questions we used in situ hybridization
to analyze colocalization of various markers with PDGFR-b.
Moreover, we studied if cells carrying these markers are able
to produce EPO under hypoxemic stimuli, targeted inhibition
of HIF degradation, and pathologic conditions. With the
production of EPO, renal interstitial PDGFR-bþ cells
contribute to the maintenance of normal tissue oxygenation.
Considering their important function as an oxygen sensor
and for hormone production, the question was raised whether
EPO-producing cells coexpress other functional regulatory
proteins in states of hypoxia.
RESULTS
Localization and quantification of PDGFR-b-expressing cells
was performed by RNAscope. On 5-mm transverse mouse
kidney sections through the renal papilla, we counted an
average of 6500 PDGFR-bþ RICs, which were distributed over
all kidney zones (Figure 1). Approximately 50% of PDGFR-
bþ RICs were located in the cortex, 40% in the OM (even
distribution between outer and inner stripe) and 10% in the
inner medulla (IM). In addition to interstitial cells, glomer-
ular mesangial cells expressed PDGFR-b.
The localization and quantification of CD73 expression
was analyzed by in situ hybridization for CD73 and PDGFR-b
mRNA. CD73 expression was located in interstitial cells,
glomerular mesangial cells, and proximal tubular cells, most
prominently in the S3 segment. Counting the colocalization
with PDGFR-b revealed that approximately 60% of all
interstitial PDGFR-bþ cells coexpressed CD73. Coexpression
occurred along a clear corticomedullary gradient (Figure 1,
top row) and was highest in the cortex (>90% of PDGFR-bþ
RICs). In the OM, coexpression only occurred in the outer
zone (45% of PDGFR-bþ RICs). In the inner zone of the OM
and in the IM, CD73/PDGFR-b coexpression was
undetectable.
Quantification of Gli1þ (glioma-associated antigen 1) cells
was investigated by immunohistochemical analysis of cells
expressing green fluorescent protein (GFP) after Gli1
promoter–driven Cre recombinase activity (Gli1CreERT2/þ
mT/mG mice). This approach was necessary, as endogenous
Gli1 expression levels are too low to allow for a robust
quantification. Approximately 15% of all PDGFR-bþ RICs
costained for Gli1-driven GFP in reporter mice, with the
highest coexpression in the outer zone of the OM. In the
cortex and in the inner zone of the OM, only few PDGFR-bþ
cells coexpressed Gli1-driven GFP. In the IM, Gli1-driven
GFP expression was almost undetectable (Figure 1, second
row).
For the quantification of SMMHC expression, as a
marker for contractile pericytes, immunohistochemistry
was performed on reporter mice expressing GFP in all
cells with Cre activity under control of the SMMHC
promoter (SMMHCCreERT2/þ mT/mG mice). SMMHC was
detected in smooth muscle cells of renal vessels and in
interstitial cells. Approximately 10% of all interstitial
PDGFR-bþ cells coexpressed SMMHC in the OM. In the
cortex and in the IM, colocalization was less than 5%
(Figure 1, third row).
Table 1 | An overview of the degree of colocalization between PDGFR-b and the respective second markers as well as the
colocalization between the additional markers among each other
Cell population CD73 Gli1 SMMHC TNC
PDGFR-b 60 15 10 25
CD73 — 15 0 0
Gli1 60 — 5 5
SMMHC 0 8 — 5
TNC 0 3 2 —
EPO in Vhl-KO mice 75 <5 5 10
EPO, erythropoietin; TNC, tenascin C.
All numbers are percentages.
First row: percentage of different subpopulations regarding interstitial PDGFR-bþ cells. Rows 2–5: percentage of colocalization of different subpopulations among each other.
To calculate the percentage for the colocalization between different subpopulations, the respective subpopulation named in the left column was set to 100%. For example,
15% of all CD73þ/PDGFR-bþ interstitial cells also expressed Gli1, but there was no colocalization between CD73 and SMMHC or TNC, respectively. Last row: percentage of
different subpopulations on PDGFR-bþ EPO-producing cells in Vhl-KO mice.
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Across the kidney, approximately 25% of all PDGFR-bþ
RICs coexpressed TNC. Coexpression of TNC by PDGFR-bþ
cells occurred along a reverse corticomedullary gradient.
Colocalization rate was low in the cortex and in the outer
zone of the OM (<5%), but increased from 65% in the inner
zone of the OM to 100% in the IM (Figure 1, bottom row).
Detection of either CD73þ, Gli1-GFPþ, SMMHC-GFPþ, or
TNCþ interstitial cells without coexpression of PDGFR-b was
very low (<3%), suggesting that these are all pure sub-
populations of interstitial PDGFR-bþ cells.
In total, we counted on average 3900 CD73þ, 950 Gli1-driven
GFPþ, 600 SMMHCþ, and 1600 TNCþ interstitial cells among
Figure 2 | Localization of cells coexpressing erythropoietin (EPO) mRNA with respective cell marker mRNA and distribution of EPOD
cells in the respective mouse models. Yellow dots indicate either EPO/marker coexpressing cells or distribution of EPO expressing cells,
respectively. Bars ¼ 500 mm. (a) Distribution of EPO expressing cells on a wild-type kidney. (b) Distribution of EPO expressing cells on a
PDGFRb-Vhl-KO kidney. (c) Localization of EPO/CD73 coexpressing cells on a PDGFRb-Vhl-KO kidney. (d) Distribution of EPO expressing cells
on a Gli1CreERT2/þ Vhlfl/fl kidney. (e) Localization of EPO/SMMHC coexpressing cells on an SMMHCCreERT2/þ Vhlfl/fl kidney. (f) Localization of EPO/
tenascin C coexpressing cells on a PDGFRb-Vhl-KO kidney. To optimize viewing of this image, please see the online version of this article at
www.kidney-international.org/.
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6500 PDGFR-bþ cells on a kidney section. Table 1 gives an
overview of the degree of colocalization between PDGFR-b and
the respective second markers as well as the colocalization be-
tween the additional markers among each other.
Coexpression of erythropoietin mRNA with different cell
markers of PDGFR-b subpopulations
On kidney sections of wild-type mice, we counted on average
10 EPO mRNA–expressing cells (Figure 2a) that were all
positive for PDGFR-b and CD73. Induction of EPO expres-
sion in PDGFR-bþ cells was achieved by the inducible dele-
tion of the von Hippel-Lindau (Vhl) gene (PDGFR-bCreERT2/þ
Vhlfl/fl, referred to as PDGFRb-Vhl-KO), which led to the
stabilization of hypoxia inducible transcription factors.13 On
kidney sections of PDGFRb-Vhl-KO mice, we counted on
average 4600 interstitial cells expressing EPO mRNA. In line
with this, PDGFRb-Vhl-KO mice were polycythemic and had
increased plasma EPO levels (Table 2) after tamoxifen
feeding. EPO expression was strongly induced in the cortex
and the OM but only to a minor extent in the IM. Approx-
imately 60% of EPOþ RICs were located in the cortex, 35% in
the OM, and less than 5% were located in the IM (Figure 2b).
In addition, on average 70 mesangial cells per kidney section
expressed EPO mRNA (Figure 3).
EPO and CD73 mRNA expression was localized by in situ
hybridization on kidney sections of PDGFRb-Vhl-KO mice.
Coexpression mirrored the zonal gradient observed for the
colocalization of CD73 with PDGFR-b (Figures 2c and 4a). It
was highest in the cortex, here more than 95% of EPOþ RICs
expressed CD73. In the OM, coexpression occurred mostly in
the outer zone (50% CD73þ EPO cells). EPO/CD73 coex-
pression in the inner zone of the OM and in the IM was
absent. In summary, over 75% of all EPOþ RICs coexpressed
CD73, suggesting an important role of interstitial CD73þ cells
for hypoxia-induced EPO expression.
To test for the ability of Gli1þ cells to express EPO, we
used mice with a conditional deletion of Vhl in Gli1þ cells
(Gli1CreERT2/þ Vhlfl/fl). After tamoxifen treatment, mice
became polycythemic and had increased plasma EPO con-
centrations and renal EPO mRNA expression levels (Table 2).
No extrarenal EPO mRNA induction was detectable. A total
of 90% of EPO-expressing cells were located in the outer
stripe of the OM. The cortex contained approximately 10%
EPO-expressing cells (Figure 2d). All EPOþ cells coexpressed
PDGFR-b (Figure 4b).
In situ hybridization for EPO and SMMHC on kidney
sections of PDGFRb-Vhl-KO mice showed that approxi-
mately 5% of all EPOþ RICs coexpressed SMMHC. SMMHC
coexpression with EPO was mostly found in the OM
(Supplementary Figure S1), where approximately 13% of
EPO cells coexpressed SMMHC (Figure 4c). However,
SMMHC is also strongly expressed by smooth muscle cells in
the walls of arteries and arterioles. Because these cells do
commonly not express PDGFR-b, hypoxia signaling in these
cells was not triggered in PDGFRb-Vhl-KO mice. To inves-
tigate the ability of SMMHCþ cells to produce EPO, we
Table 2 | Hematocrit values, plasma EPO concentrations, and relative EPO mRNA expression levels in control mice, PDGFR-
bCreERT2/D Vhlfl/fl mice, Gli1CreERT2/D Vhlfl/fl mice, and SMMHCCreERT2/D Vhlfl/fl mice after feeding a tamoxifen containing chow for
4 weeks
Genotype Hematocrit values (%) Plasma EPO concentrations (pg/ml) EPO mRNA expression level (a.u.)
Control 49.8  0.6 137.9  18.8 1.0  0.2
PDGFR-bCreERT2/þ Vhlfl/fl 71.9  1.5 121,026.0  13,019.0 183.1  10.9
Gli1CreERT2/þ Vhlfl/fl 70.8  0.8 1335.9  95.6 20.8  4.5
SMMHCCreERT2/þ Vhlfl/fl 69.2  1.6 1278.9  93.0 9.6  1.5
a.u., arbitrary units; EPO, erythropoietin.
Values are the mean  SEM of 8 mice in each group.
Figure 3 | Erythropoietin (EPO) mRNA expression in glomeruli, presumably mesangial cells. (a–c) EPO expression was found in 1–3
intraglomerular cells in approximately 35% of glomeruli (encircled) per kidney section of PDGFRb-Vhl-KO mice. Bars ¼ 50 mm. To optimize
viewing of this image, please see the online version of this article at www.kidney-international.org/.
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generated SMMHCCreERT2/þ Vhlfl/fl mice. After induction,
mice were polycythemic and had increased plasma EPO
concentrations and renal EPO mRNA expression levels
(Table 2). No extrarenal EPO mRNA induction was found in
these mice. Localization of EPO mRNA in these kidneys
(Figure 2e) was similar to the colocalization of EPO and
SMMHC in kidneys of PDGFRb-Vhl-KO mice
(Supplementary Figure S1). Smooth muscle cells of arteries
and arterioles did not express EPO.
EPO and TNCmRNAwas localized on sections of PDGFRb-
Vhl-KO mice. Coexpression of EPO and TNC was less than 5%
in the cortex and in the outer zone of theOM. In the inner stripe
of the OM, approximately 30% of EPOþ RICs coexpressed
TNC. In the IM, all EPO-expressing cells colocalized with TNC
(Figures 2f and 4d). However, there were a large number of
TNCþ cells in the IM, which did not express EPO.
In total, we counted an average of 3500 CD73þ, 200
SMMHCþ, 450 TNCþ, and 160 Gli1-inducible EPO-
Figure 4 | Cohybridization of erythropoietin (EPO) mRNA with different cell marker mRNAs in the kidney cortex, outer stripe of the
OM (osOM), inner stripe of the OM (isOM), and inner medulla (IM). Yellow color results from merger of red and green fluorescence and
indicates coexpression of 2 different mRNAs. Bars ¼ 50 mm. Top row: colocalization of EPO mRNA (green) and CD73 mRNA (red) on a section
of a PDGFRb-Vhl-KO kidney. In the cortex, almost all EPO-producing cells expressed CD73; in the osOM, colocalization was approximately
50%; and in the isOM and IM, there were no EPOþ/CD73þ cells. Second row: colocalization of EPO mRNA (green) and PDGFR-bmRNA (red) on
a section of a Gli1CreERT2/þ Vhlfl/fl kidney. EPO mRNA–expressing cells were mainly found in the outer zone of the OM. All EPO mRNA–
expressing cells also expressed PDGFR-b. Third row: colocalization of EPO mRNA (green) and SMMHC mRNA (red) on a section of a PDGFRb-
Vhl-KO kidney. Coexpression was highest in the OM, where approximately 15% of EPO-expressing cells coexpressed SMMHC. Bottom row:
colocalization of EPO (green) and tenascin C (TNC; red) on a section of a PDGFRb-Vhl-KO kidney. In the cortex and outer zone of the OM, no
cohybridization became apparent, whereas in the inner zone of the OM, approximately 25% of EPO-expressing cells coexpressed TNC. In the
IM, only a minority of TNCþ cells expressed EPO mRNA. To optimize viewing of this image, please see the online version of this article at www.
kidney-international.org/.
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Figure 5 | Localization of cells expressing erythropoietin (EPO) mRNA after 2 different hypoxic stimuli and pathologic conditions in
wild-type and PDGFRb-Vhl-KO kidneys. Yellow dots indicate EPO-producing cells. The white dotted line indicates the border between the
cortex and the outer stripe of the outer medulla. Nuclei were counterstained with 40,6-diamidino-2-phenylindole. Bars ¼ 500 mm. (a) Kidney
section of a wild-type mouse treated with 8% O2 for 3 hours. Recruitment of additional EPO-expressing cells occurred mostly in the cortical
region and to a minor extent (20%) in the outer stripe of the outer medulla. (b) Kidney section of a wild-type mouse treated with 0.1% CO for
4 hours. The number of EPO mRNA–producing cells was greatly increased mostly in the cortex. Moreover, 21% of the additional EPO-
expressing cells were recruited in the outer stripe of the outer medulla. (c) In a 10-day unilateral ureteral obstruction (UUO) kidney of a wild-
type mouse, EPO expression was reduced. Interestingly, few EPO-producing cells could be detected in the inner medulla (IM). (d) In a 10-day
UUO kidney of a PDGFRb-Vhl-KO mouse, a large number of EPO-expressing cells were still detectable in the cortex and the outer medulla.
However, EPO production was reduced compared with a healthy PDGFRb-Vhl-KO kidney. There were also still some EPO-producing cells in
the IM. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org/.
Figure 6 | Double fluorescent in situ hybridization for erythropoietin (EPO) (green) and CD73 (red) mRNA on kidney sections of wild-
type mice exposed to (a) low oxygen or (b) CO. Under both conditions, EPO-producing cells were mainly located in the cortex in a grouped
fashion. The recruited EPOþ cells were mostly part of the CD73þ subpopulation. Circles indicate glomeruli. Bars ¼ 50 mm. To optimize viewing
of this image, please see the online version of this article at www.kidney-international.org/.
bas i c re sea r ch KAE Broeker et al.: Subpopulations of renal interstitial PDGFRb+ cells
924 Kidney International (2020) 98, 918–931
expressing cells among the average 4600 EPOþ cells on kidney
sections of PDGFRb-Vhl-KO mice (Table 1).
To evaluate the contribution of different PDGFR-b sub-
populations to the EPO production in wild-type mice with
nongenetic induction of the hypoxia-signaling pathway, we
exposed mice to either low oxygen (8% O2 for 3 hours) or
carbon monoxide (0.1% CO for 4 hours). RNAscope for EPO
mRNA on kidney sections of these mice showed a recruitment
of EPO-producing cells predominantly along the cortico-
medullary border and in the cortex for both conditions
(Figure 5a and b). Compared with normoxic conditions the
number of EPOþ cells increased 24-fold under low oxygen
conditions and approximately 100-fold after CO exposure.
The recruitment of EPO-producing cells occurred in a
cluster-like fashion. These cells coexpressed CD73 (Figure 6)
along with PDGFR-b. Some EPO-expressing cells were posi-
tive for Gli1, but none for SMMHC or TNC (Table 3).
In chronic kidney disease in human patients, EPO pro-
duction in the kidney declines drastically.15,16 Therefore, we
induced kidney fibrosis in mice using 10 days’ unilateral
ureteral obstruction (UUO) to evaluate which cells are able to
produce EPO under these conditions. In wild-type mice, only
few cortical EPO cells were detected in the UUO kidney
(Figure 5c), which belonged to the CD73 subpopulation.
Interestingly, a number of EPOþ cells were detectable in the
remaining tissue of the IM. These atypically located EPO cells
belonged to the TNC subpopulation. The UUO kidneys of
PDGFRb-Vhl-KO mice still showed a strong EPO mRNA
signal in CD73þ cells of the kidney cortex (Table 3). We could
also detect some EPOþ cells in the IM as under basal con-
ditions. There was however only weak EPO expression in the
damaged fibrotic zone of the OM (Figure 5d), where a strong
induction of a-SMA mRNA could be detected by RNAscope
(Supplementary Figure S2).
ADM and RGS4 coexpression with EPO
Previous data of mesangial cells with Vhl deletion showed a
strong upregulation for EPO, regulator of G protein signaling
4 (RGS4), and adrenomedullin (ADM).24 Expression of these
genes was also upregulated in PDGFRb-Vhl-KO kidneys
(Table 4). With additional deletion of Hif-2a (PDGFR-
bCreERT2/þ Vhlfl/fl Hif-2afl/fl mice), the induction of these
mRNAs was almost absent, suggesting an HIF-2-regulated
gene transcription similar to EPO. ADM and RGS4 mRNA
abundance was increased in all zones of PDGFRb-Vhl-KO
kidneys (Figure 7). Compared with the zonal expression of
EPO, which showed the highest abundance in the OM and the
lowest abundance in the IM, ADM and RGS4 were more
evenly distributed across the different kidney zones. We
therefore analyzed cellular coexpression of EPO with ADM or
RGS4 under different conditions.
Wild-type kidneys showed a weak basal expression of
ADM and RGS4 in glomeruli and some PDGFR-bþ RICs
(Figures 8a and 9a). In addition, ADM could be detected in
certain cortical tubules (Figure 8a) and RGS4 in vascular
smooth muscle cells (Figure 9a). Using in situ hybridization
Table 3 | Average number of EPO-producing cells per transverse kidney section, their localization, and contributing
subpopulations of PDGFR-bD interstitial cells
Treatment/genotype
Average number of
EPOD cells per section Localization of EPOD cells Subpopulations
Untreated wild-type 10  3 >99% cortex
<1% osOM
CD73
8% O2 for 3 h 242  35 80% cortex
20% osOM
CD73, Gli1








PDGFRb-Vhl-KO UUO 1732  114 65% cortex
34% OM
<1% IM
CD73, Gli1, SMMHC, TNC
EPO, erythropoietin; IM, inner medulla; isOM, inner stripe of outer medulla; OM, outer medulla; osOM, outer stripe of outer medulla; TNC, tenascin C; UUO, unilateral ureteral
obstruction.
Table 4 | Relative mRNA abundance of EPO, ADM and RGS4 of control, PDGFR-bCreERT2/D Vhlfl/fl, and PDGFR-bCreERT2/D Vhlfl/fl
Hif-2afl/fl kidneys
mRNA/RPL32mRNA (a.u.) Control PDGFR-bCreERT2/D Vhlfl/fl PDGFR-bCreERT2/D Vhlfl/fl Hif2afl/fl
EPO 1.0  0.2 190.0  15.0 1.5  0.4
ADM 1.0  0.05 4.0  0.3 1.4  0.2
RGS4 1.0  0.1 14.0  3.0 1.2  0.3
ADM, adrenomedullin; EPO, erythropoietin; RGS4, regulator of G protein signaling 4.
mRNA expression levels of control mice are set to 1 and serve as a reference. Data are means  SEM of 5 mice in each group.
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we found that all EPOþ cells in wild-type kidneys coexpress
ADM and RGS4 (Figures 8b and 9b). In PDGFRb-Vhl-KO
kidneys, ADM and RGS4 mRNA expression was increased in
mesangial and interstitial cells of all kidney zones including
the IM (Figures 8d and 9d). Interstitial ADM and RGS4
expression colocalized well with EPO expression. ADM and
RGS4 also colocalized with all the markers described for EPO
above (not shown). Moreover, in SMMHCCreERT2/þ Vhlfl/fl
and Gli1CreERT2/þ Vhlfl/fl kidneys, ADM and RGS4 colocalized
with EPO. Under hypoxemic conditions with low O2 or CO
treatment, we could detect a distinct upregulation of ADM
and RGS4 predominantly in RICs that also started to express
Figure 7 | Zonal mRNA expression levels of erythropoietin (EPO), adrenomedullin (ADM), and regulator of G protein signaling 4
(RGS4) in control kidneys compared with PDGFRb-Vhl-KO kidneys. EPO, ADM, and RGS4 mRNA abundance was increased in all zones of
PDGFRb-Vhl-KO kidneys. The cortex of control kidneys is set to 1. Data are means  SEM of 5 mice in each group. *P < 0.05 versus controls.
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EPO (Figures 8c and 9c). UUO had no effect on the inter-
stitial ADM and RGS4 mRNA expression of the kidney.
DISCUSSION
On the basis of our findings that renal cells capable of pro-
ducing EPO carry the PDGFR-b,13 this study aimed to further
characterize potential renal EPO-producing cells. We found
EPO mRNA–expressing cells in the interstitium of the cortex,
the OM, and less in the IM after inducible deletion of Vhl in
PDGFR-bþ cells.13 This broad interzonal distribution of po-
tential EPO-expressing cells is not specific for the deletion of
Vhl but can also be produced by deletion of HIF prolyl-4-
hydroxylase 2 in the FoxD1 cell lineage9 and by severe
anemia.2
In accordance with previous reports, we identified sub-
populations of PDGFR-bþ cells, which expressed CD73,
Gli1, SMMHC, and TNC.21,22,25 PDGFR-bþ/CD73þ RICs
were located in the cortex, including the border between the
cortex and the OM. PDGFR-bþ/Gli1þ RICs were predom-
inantly found in the outer zone of the OM. PDGFR-bþ/
SMMHCþ cells were mainly detected in the OM. PDGFR-
bþ/TNCþ cells were located in the IM and in the inner
zone of the OM. Again, these results are in good accordance
with previous reports.21,22,26 After inducible deletion of Vhl
from PDGFR-bþ cells, we found EPO expression in nearly
all interstitial CD73þ cells, which made up approximately
65% of all PDGFR-bþ EPO-expressing cells. This observa-
tion supports previous reports identifying nontubular
CD73þ cells as the quantitative dominant intrarenal site of
physiologic EPO production.1,2 The remaining 35% of
EPO-expressing PDGFR-bþ cells were mostly localized in
the OM, where CD73þ, Gli1þ, TNCþ, and interstitial
SMMHCþ cells were found.21,22,27 The cell-specific deletion
of Vhl in Gli1þ cells induced EPO expression and caused
polycythemia. These results are supported by a recent study
suggesting Gli1þ cells as possible production sites for
EPO.28 EPO-expressing cells showed the characteristic stel-
late appearance described for EPO-expressing cells of
anemic kidneys10,14 or of PDGFR-bCreERT2/þ Vhlfl/fl mice13
(Supplementary Figure S3). Gli1þ cells are considered
closely related to pericytes, which transform into myofi-
broblasts in states of interstitial kidney fibrosis.29,30
In addition, cells expressing SMMHC appear as potential
EPO producers. Apparently, only interstitial SMMHCþ cells,
Figure 8 | Colocalization of adrenomedullin (ADM) with either PDGFR-b or erythropoietin (EPO). Circles indicate glomeruli. Bars ¼ 50
mm. (a) RNAscope for ADM (red) and PDGFR-b (green) in the cortex of a wild-type kidney. Weak ADM expression was detected in glomerular
mesangial cells, some interstitial PDGFR-bþ cells, and certain tubular segments (arrows). (b) RNAscope for ADM (red) and EPO (green) on a
wild-type kidney. All native EPO-expressing renal interstitial cells (RICs) also express ADM. (c) ADM (red) and EPO (green) expression on a
kidney section of a wild-type mouse exposed to 8% O2 for 3 hours. ADM was upregulated in all recruited EPO cells. Tubular ADM expression
was not affected by low oxygen treatment (arrows). (d) In PDGFRb-Vhl-KO kidneys, ADM (red) was strongly upregulated in all cells affected by
the deletion of Vhl, namely glomerular mesangial cells and RICs. All EPO (green)-expressing cells of PDGFRb-Vhl-KO mice showed a strong
upregulation of ADM. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org/.
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but not vascular smooth muscle cells in the preglomerular
arteries and arterioles, could express EPO after deletion of
Vhl. We therefore consider SMMHCþ RICs able to express
EPO as contractile pericytes.31 These cells are known to play a
role in the regulation of medullary blood flow.31,32 In addition
to CD73þ, Gli1þ, and SMMHCþ RICs, a subset of medullary
TNCþ RICs appear to have the potential for EPO production.
To analyze the contribution of these subpopulations to the
EPO-producing cells under hypoxemic conditions, we
exposed mice to either low O2 or CO. Recruitment of EPO
cells occurred cluster-like along the corticomedullary border
and spread throughout the kidney cortex, as described pre-
viously (Figure 5a and b).4,7,33 The majority of the recruited
EPO cells could be assigned to the CD73þ subpopulation of
PDGFR-bþ interstitial cells (Figure 6). In the outer stripe of
the OM, Gli1þ cells also contributed to the additional EPO
production, whereas the SMMHC and TNC subpopulations
did not play a role under these conditions. These results are in
good accordance with previous findings.1,8,28
Interestingly, the TNCþ RICs identified in this study seem
to play a role during experimental kidney fibrosis. During
UUO this subpopulation of potential EPO-producing cells
sustained a de novo expression of EPO mRNA in the IM
whereas EPO production in the kidney cortex declined
(Figure 5c). This is noteworthy because under basal condi-
tions EPO expression could not be detected in the IM of
wild-type mice. The kidneys of PDGFRb-Vhl-KO mice
retained a strong cortical EPO mRNA expression during
UUO, but cells in the high fibrotic zone in the OM lost the
ability to express EPO whereas they started to express a-
SMA (Supplementary Figure S2).12,14,17,34 Sporadically,
EPOþ cells could be detected that expressed a-SMA mRNA
at the same time, but the EPO signal was already weaker in
these cells compared with a-SMA EPO cells.7 In the IM of
these mice, also a number of TNCþ EPO-producing cells
could still be detected (Figure 5d). These findings suggest
that the TNCþ subpopulation has the potential of producing
EPO in this model of kidney fibrosis. This could eventually
Figure 9 | Colocalization of regulator of G protein signaling 4 (RGS4) with either PDGFR-b or erythropoietin (EPO). Circles indicate
glomeruli. Bars ¼ 50 mm. (a) RNAscope for RGS4 (red) and PDGFR-b (green) on a wild-type kidney. In the cortical region, weak RGS4 expression
was detected in some glomerular mesangial cells, interstitial PDGFR-bþ cells, and renal vessels. (b) RNAscope for RGS4 (red) and EPO (green)
under basal conditions. All native EPO-expressing renal interstitial cells (RICs) also expressed RGS4. (c) RGS4 (red) and EPO (green) expression
on a kidney section of a wild-type mouse exposed to 8% O2 for 3 hours. RGS4 was expressed similar to adrenomedullin in all EPO-producing
cells and in RICs close to EPO cells. (d) In PDGFRb-Vhl-KO kidneys, RGS4 (red) was strongly upregulated in all cells affected by the deletion of
Vhl, glomerular mesangial cells, and RICs. All EPO (green)-expressing cells of PDGFRb-Vhl-KO mice showed a strong upregulation of RGS4. To
optimize viewing of this image, please see the online version of this article at www.kidney-international.org/.
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be used as a new target for further investigations and
pharmaceutical development.
In this study, novel insights into the expression pattern of 2
factors influencing the local tissue oxygenation could be ob-
tained. On one hand, we could show that ADM and RGS4 are
coexpressed in EPO-producing cells under basal conditions
(Figures 8b and 9b). On the other hand, we could detect that
ADM and RGS4 were significantly coinduced in all EPOþ
cells after Vhl deletion in PDGFR-bþ cells of the kidney as
well as under hypoxemic conditions (Figures 8 and 9). These
results are in good accordance with other studies showing the
hypoxia inducibility of ADM and RGS4.35–39 ADM has been
described to increase renal perfusion as well as salt and water
excretion.40,41 Therefore, it is conceivable that hypoxemic
induction of ADM production in the interstitium leads to an
increase in interstitial perfusion and to a lowering of energy
consuming sodium resorption. Both mechanisms could
contribute to improving the interstitial oxygenation in states
of hypoxia. Similarly, RGS4 expression in perivascular
PDGFR-bþ cells could contribute to counteracting or atten-
uating vasoconstrictor effects of mediators acting via Gq
proteins. Some evidence for such a vascular and renopro-
tective effect of RGS4 has already been provided.42–44
Taken together, it is conceivable that PDGFR-bþ RICs play
an important role as an oxygen-sensing system that helps the
kidney to improve tissue oxygenation in states of hypoxia. It is
noteworthy in this context that in the normal kidney EPO,
ADM, and RGS4 mRNA levels are very low in interstitial
PDGFR-bþ cells but substantially increase after induction of
HIF signaling.Moreover, wewant to highlight that the PDGFR-
bþ RICs can be subdivided into different subpopulations,
which are in principle able to produce EPO. Depending on the
stimulus, different subpopulations are recruited to express
EPO. Under hypoxemic conditions, CD73þ and Gli1þ cells
predominantly contribute to EPO production, whereas under
profibrotic pathologic situations, TNCþ RICs seem to be
activated. Because of the wide intrarenal distribution and high
number of potential EPO/ADM/RGS4-producing PDGFR-bþ
RICs, this cell pool will form a target for newly developed drugs
such as HIF prolyl-4-hydroxylase-inhibitors, which not only
stimulate EPO production but could also ameliorate progres-
sion of renal disease.45–47
MATERIALS AND METHODS
Animals
PDGFR-bCreERT2/þ Vhlfl/fl and PDGFR-bCreERT2/þ Vhlfl/fl HIF-2afl/fl
mice were generated by crossbreeding PDGFR-bCreERT2 mice
(tamoxifen-inducible Cre recombinase expression under the control
of the PDGFR-b promoter; JAX stock #029684)24 and mice with
loxP-flanked Vhl alleles48 or additionally with mice with loxP-
flanked HIF-2a alleles.49 Gli1CreERT2/þ Vhlfl/fl and
SMMHCCreERT2/þ Vhlfl/fl mice were generated by crossbreeding
Gli1CreERT2 mice (tamoxifen-inducible Cre recombinase under the
control of the Gli1 gene promotor; JAX stock #007913),50 or
SMMHCCreERT2 mice (tamoxifen-inducible Cre recombinase under
the control of the SMMHC gene promotor; JAX stock #19079)51 and
Vhlfl/fl mice. For Gli1 and SMMHC lineage tracing, Gli1CreERT2 mice
and SMMHCCreERT2 mice were crossed with the membrane-Tomato/
membrane-GFP (mT/mG; JAX stock #007676)52 reporter mouse
strain (Gli1CreERT2/þ mT/mG and SMMHCCreERT2/þ mT/mG).
Genotyping was performed using the primers listed in Table 5.
Animals were maintained on standard rodent chow (0.6% NaCl;
Ssniff, Soest, Germany) with free access to tap water. All animal
experiments were performed according to the Guidelines for the
Care and Use of Laboratory Animals published by the US National
Institutes of Health and approved by the local ethics committee.
Tamoxifen treatment
Cre-mediated recombination was induced by feeding a diet con-
taining 400-mg tamoxifen citrate per kilogram (A115T00404; Ssniff)
for 4 weeks followed by a 3-week period with standard chow.
Unilateral ureteral obstruction
Under inhalation anesthesia, a unilateral ureteral ligation was placed
close to the kidney through an abdominal incision. Mice were kept
under close observation after the operation. Ten days after the
procedure mice were perfused with 10% neutral buffered formalin
solution.
Table 5 | Primer sequences used for genotyping







Table 6 | RNAscope probesa used for in situ hybridization









2.5 Duplex Positive Control Probe -Mm 321651
2-plex Negative Control Probe 320751
Positive Control Probe- Mm-Ppib 313911
Negative Control Probe-DapB 310043
aAdvanced Cell Diagnostics, Newark, CA.
Table 7 | Primer sequences used for qPCR













ADM, adrenomedullin; EPO, erythropoietin; RGS4, regulator of G protein signaling 4;
RPL32, ribosomal protein L32.
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Low oxygen and CO exposure
To induce EPO production in kidneys of wild-type mice, these were
placed either for 3 hours in a chamber containing only 8% O2 or for
4 hours in a 0.1% CO atmosphere as described previously.10 Animals
were killed immediately at the end of the experiment for histologic
analysis.
In situ hybridization via RNAscope
Localization of target mRNA was studied by using the RNAscope
Multiplex Fluorescent v2 kit (Advanced Cell Diagnostics, Newark,
CA), according to the manufacturer’s instructions.53 Hybridiza-
tion signals were detected on 5-mm formalin-fixed paraffin-
embedded transverse kidney sections using the TSA Plus fluo-
rophores Cy3 and Cy5 (PerkinElmer, Waltham, MA). Slices were
mounted with ProLong Gold Antifade Mountant (Thermo Fisher
Scientific, Waltham, MA) and viewed with an Axio Observer.Z1
Microscope (Zeiss, Jena, Germany). To ensure interpretable re-
sults, positive and negative controls were routinely included.
RNAscope probes used are listed in Table 6.
Immunohistochemistry
Five-micrometer sections of formalin-fixed paraffin-embedded kid-
neys were blocked with 10% horse serum/1% bovine serum albumin
in phosphate-buffered saline and incubated with chicken anti-GFP
(ab13970; Abcam, Cambridge, UK) and rabbit anti-PDGFR-b
(ab32570; Abcam) or rabbit anti-SMMHC (ab53219; Abcam) anti-
bodies at 4 C overnight. After washing with bovine serum albumin/
phosphate-buffered saline, sections were stained with Cy2 and Tritc
secondary antibodies (Dianova, Hamburg, Germany), mounted with
Glycergel (Agilent, Waldbronn, Germany), and viewed with an Axio
Observer.Z1 Microscope.
Cell counting
Cell counting was performed using ImageJ software. Kidneys of 3
mice per genotype were analyzed for each colocalization study. Cells
were counted on 3 different sections per kidney by manually placing
a marker (plugin “cell counter notice”). Counting was performed by
2 persons independently in a blinded fashion.
Determination of mRNA expression by real-time polymerase
chain reaction
Total RNA was isolated from kidneys as described by Chomczynski
and Sacchi54 and quantified by a photometer. One microgram of the
resulting RNA was used for reverse transcription. cDNA was syn-
thesized by Moloney murine leukemia virus RT (Thermo Fisher
Scientific). For the quantification of mRNA expression, real-time
polymerase chain reaction was performed using a Light Cycler In-
strument and the LightCycler 480 SYBR Green I Master Kit (Roche
Diagnostics, Mannheim, Germany). mRNA expression data were
normalized to ribosomal protein L32. Table 7 lists primer sequences.
Determination of hematocrit values and plasma EPO
concentrations
Blood samples were taken from tail vein into ethylenediamine tet-
raacetic acid–coated capillary tubes. Hematocrit values were deter-
mined after centrifugation (4 minutes, 12,000 rpm, room
temperature). EPO protein concentration was determined in plasma
samples using the Quantikine Mouse EPO ELISA kit (BioTechne,
Minneapolis, MN), according to the manufacturer’s protocol.
Statistical analyses
All data are presented as means  SEM. Statistical significance was
determined by Student’s t test. P < 0.05 was considered statistically
significant. Data were analyzed using Prism 5 (GraphPad Software,
San Diego, CA).
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Figure S1. Localization of cells coexpressing EPO and SMMHC mRNA
on a PDGFRb-Vhl-KO kidney.
Figure S2. Details of the outer medulla of a double in situ
hybridization for EPO and a-SMA mRNA on a UUO kidney section of a
PDGFRb-Vhl-KO mouse.
Figure S3. Chromogenic RNAscope for EPO mRNA on kidney sections
of Gli1CreERT2/þ Vhlfl/fl mice in detail.
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Supplementary Material 
 
Supplementary Figure S1: Localization of cells coexpressing EPO and SMMHC mRNA on a PDGFRβ-Vhl-
KO kidney highlighted with yellow dots. Distribution of EPO/SMMHC expressing cells is similar to the 








Supplementary Figure S2: Details of the outer medulla of a double in situ hybridization for EPO (green) 
and α-SMA (red) mRNA on an UUO kidney section of a PDGFRβ-Vhl-KO mouse. (A) Almost no EPO 
expression could be detected in zones strongly expressing the fibrotic marker α-SMA. EPO expression 
was retained in non-fibrotic areas. Scale bar = 50 µm. (B) and (C) Few EPO+ cells coexpressed α-SMA 
(arrows), but EPO mRNA expression was already lower in these cells compared to EPO expressing cells 




Supplementary Figure S3: Chromogenic RNAscope for EPO mRNA on kidney sections of Gli1CreERT2/+ 
Vhlfl/fl mice in detail. EPO producing cells show the typical stellate shape. Scale bars = 20 µm. 
 
 
 

